The International Society for Stem Cell Research (ISSCR) released an update of its 2021 Guidelines for Stem Cell Research and Clinical Translation today. The targeted update addresses significant advances in the development and application of human stem cell-based embryo models (SCBEMs) and recommendations for research oversight outlined in a white paper from the ISSCR Embryo Models Working Group…
Flow Cytometry Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the flow cytometry industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected flow cytometry market growth numbers 2021-2030.
View Complete Report:
https://www.thebusinessresearchcompany.com/report/flow-cytometry-global-market-report
The Flow Cytometry Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global flow cytometry market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Flow Cytometry Global Market Report 2021 covers flow cytometry market drivers, flow cytometry market trends, flow cytometry market growth rate, flow cytometry market major players, player-adopted strategies in the market, and flow cytometry market size.
The global flow cytometry market is expected to grow from $4.11 billion in 2020 to $4.52 billion in 2021 at a compound annual growth rate (CAGR) of 10%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The flow cytometry market is expected to reach $6.07 billion in 2025 at a CAGR of 7.6%.
Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2509&type=smp
The report covers the flow cytometry market segments-
1) By Type: Instruments, Reagents & Consumables, Software, Accessories, Services
2) By Technology: Cell-Based, Bead-Based
3) By End User: Hospitals And Clinics, Academia And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
4) By Application: Oncology, Drug Discovery, Disease Diagnosis, Stem Cell Therapy, Organ Transplantation, Hematology
About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information:
The Business Research Company
https://www.thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/
#Importance Of Stem Cell Therapy In #Covid-19
To know more about Stem Cell Therapy in Covid, Visit www.globalstemcellcare.com
FDA authorizes first T cell-based test to detect prior SARS-CoV-2
(HealthDay)—The T-Detect COVID Test, a T cell-based test that helps to identify individuals with recent or prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, was granted emergency use authorization, the U.S. Food and Drug Administration announced Friday.
The next-generation sequencing-based test analyzes DNA sequences to identify those with an adaptive T cell immune…
Scientists in the United States said Tuesday they were developing a faster, more efficient way of gauging the toxicity of chemicals, which may reduce the need for animal testing.Using human cells in Petri dishes in the lab, they tested about 10,000 different types of……
Newsmax Health – Health NewsCell-Based Tests May Reduce Need to Use Animals
Cell-Based Tests May Reduce Need to Use Animals was originally published on Health And Fitness Today
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines
Microfluidic cell-squeezing device opens new possibilities for cell-based vaccines
Researchers have shown that they can use a microfluidic cell-squeezing device to introduce specific antigens inside the immune system’s B cells, providing a new approach to developing and implementing antigen-presenting cell vaccines.
